QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
Many men undergo holmium laser enucleation of the prostate (HoLEP) to relieve urinary symptoms caused by an enlarged prostate. If prostate cancer is diagnosed later, patients often wonder whether their earlier surgery will affect their treatment options. Researchers reviewed more…
After surgery or radiation therapy, some men’s PSA levels begin to rise again, suggesting that prostate cancer may have returned. Finding the location of recurrent cancer is critical because it helps physicians choose the most appropriate treatment. Researchers reviewed 43…
Immunotherapy has transformed the treatment of several cancers, but it has had limited success against prostate cancer. Scientists continue searching for ways to make prostate tumors more responsive to the body’s immune system. Researchers have developed microscopic silica particles, called…
Over the past 20 years, physicians have increasingly recognized that many men with low-risk prostate cancer can be safely managed with active surveillance, allowing treatment to be delayed or avoided unless the cancer shows signs of becoming more aggressive….
After radical prostatectomy, doctors routinely measure PSA levels to determine whether all of the cancer has been removed. Traditionally, this blood test has been performed about six to eight weeks after surgery. Researchers studying more than 43,000 men found that,…
A large international study combined the results of 13 clinical trials involving more than 10,000 men with localized prostate cancer to determine the best length of androgen deprivation therapy (ADT), or hormone therapy, when it is given with radiation…
Researchers evaluated 40 men with locally advanced or lymph node-positive prostate cancer who underwent robot-assisted radical prostatectomy with extensive lymph node removal, followed immediately by hormone therapy. All patients had PSA levels greater than 20 ng/mL before surgery and were…
A Phase 2 clinical trial studied whether PSMA PET scans could improve radiation treatment for men whose PSA began to rise after radical prostatectomy, a sign that prostate cancer may have returned. The study included 128 men who were randomly…
Researchers combined the results of seven clinical trials involving 574 men with oligometastatic prostate cancer, meaning the cancer had spread to five or fewer sites. The goal was to determine whether treating these individual metastatic spots with surgery or highly…
The Clinical Society of Genitourinary Surgeons is an exclusive, invitation-only professional organization consisting of leading academic urologists and surgeons. It’s primary focus is advancing urological science, exchanging clinical knowledge, and hosting high-level annual scientific meetings. It’s membership limited strictly to…
"*" indicates required fields
